de Jong Roy G P J, Gallagher Arlene M, Herrett Emily, Masclee Ad A M, Janssen-Heijnen Maryska L G, de Vries Frank
Department of Internal Medicine, VieCuri Medical Centre, Venlo, The Netherlands.
Department of Internal Medicine, Division of Gastroenterology and Hepatology, GROW School for Oncology and Developmental Biology, Maastricht University Medical Centre+, Maastricht, The Netherlands.
Pharmacoepidemiol Drug Saf. 2016 Dec;25(12):1460-1464. doi: 10.1002/pds.4074. Epub 2016 Jul 27.
The UK Clinical Practice Research Datalink (CPRD) is increasingly being used by Dutch researchers in epidemiology and pharmacoepidemiology. It is however unclear if the UK CPRD is representative of the Dutch population and whether study results would apply to the Dutch population. Therefore, as first step, our objective was to compare the age and sex distribution of the CPRD with the total Dutch population.
As a measure of representativeness, the age and sex distribution of the UK CPRD were visually and numerically compared with Dutch census data from the StatLine database of the Dutch National Bureau of Statistics in 2011.
The age distribution of men and women in the CPRD population was comparable to the Dutch male and female population. Differences of more than 10% only occurred in older age categories (75+ in men and 80+ in women).
Results from observational studies that have used CPRD data are applicable to the Dutch population, and a useful resource for decision making in the Netherlands. Nevertheless, differences in drug exposure likelihood between countries should be kept in mind, as these could still cause variations in the actual population studied, thereby decreasing its generalizability. Copyright © 2016 John Wiley & Sons, Ltd.
英国临床实践研究数据链(CPRD)越来越多地被荷兰研究人员用于流行病学和药物流行病学研究。然而,尚不清楚英国CPRD是否能代表荷兰人群,以及研究结果是否适用于荷兰人群。因此,作为第一步,我们的目标是将CPRD的年龄和性别分布与荷兰总人口进行比较。
作为代表性的一种衡量方式,将英国CPRD的年龄和性别分布与荷兰国家统计局StatLine数据库2011年的荷兰人口普查数据进行了直观和数值上的比较。
CPRD人群中男性和女性的年龄分布与荷兰男性和女性人口相当。仅在老年类别中出现了超过10%的差异(男性为75岁及以上,女性为80岁及以上)。
使用CPRD数据的观察性研究结果适用于荷兰人群,是荷兰决策的有用资源。然而,应牢记各国之间药物暴露可能性的差异,因为这些差异仍可能导致所研究实际人群的变化,从而降低其普遍性。版权所有© 2016约翰·威利父子有限公司。